<DOC>
	<DOCNO>NCT00501709</DOCNO>
	<brief_summary>Pancreatic islet part pancreas produce insulin help control blood sugar . This study aim improve islet transplantation treatment Type 1 Diabetes use new combination immunosuppressive drug successful treat autoimmune disease prevent kidney transplant rejection .</brief_summary>
	<brief_title>Prevention Autoimmune Destruction Rejection Human Pancreatic Islets Following Transplantation Insulin Dependent Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>Type 1 Diabetes Metabolic lability/instability characterize hypoglycemia ketoacidosis ( &gt; 2 hospital admission previous year ) , erratic glucose profile ( MAGE &gt; 120mg/dL ) , disruption lifestyle ( danger life , self others ) . Reduced awareness hypoglycemia &gt; 1 episode last 1.5 year severe hypoglycemia . Persistently poor glucose control ( define HgbA1c &gt; 10 % end six month intensive management effort diabetes care team . Progressive secondary complication define new diagnosis ophthalmologist proliferative retinopathy clinically significant macular edema therapy photocoagulation last year ; urinary albumin excretion rate &gt; 300mg/day proteinuria &lt; 3g/day ; symptomatic autonomic neuropathy ( defined postural hypotension set euvolemia , gastroparesis diarrhea attribute diabetic neuropathy , neuropathic bladder diagnose urologist ) Patient weigh 80kg body mass index BMI &gt; 28 Patient 's insulin requirement &gt; 55 Units/day . Current use immunosuppressive agent . History malignancy within 10 year ( except adequately treat basal squamous cell CA skin ) . Active peptic ulcer disease . Severe unremitting diarrhea GI disorder potentially interfere ability absorb oral medication . Untreated proliferative retinopathy . Pregnancy breastfeed . Female subject postmenopausal surgically sterile , use acceptable method contraception . Active infection . Major ongoing psychiatric illness . Ongoing substance abuse , drug alcohol ; recent history noncompliance . Portal hypertension history significant liver disease . Lymphopenia ( &lt; 1000/ul ) leukopenia ( &lt; 3000 total leukocytes/ul ) absolute CD4 count &lt; 500/ul . Presence history panelreactive antiHLA antibody &gt; 20 % . Evidence acute EBV infection ( IgM &gt; IgG ) OR serologic evidence previous exposure EBV ( IgG &gt; IgM ) . Serologic evidence infection HIV HbsAg HCV Ab positive . Creatinine clearance &lt; 60ml/min/m2 . Positive lymphocytoxic crossmatch use donor lymphocyte serum</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>